Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06830993 · ClinicalTrials.gov registry record · NA
Physical Activity Prescription Program for Hemodialysis Patients
A NA study of Hemodialysis, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06830993: Recruiting NA study of Hemodialysis, sponsored by University of Arizona.
NCT06830993 is a NA study of Hemodialysis that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 40 participants, below the 136-participant average among 12 other Hemodialysis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06830993, a NA study of Hemodialysis, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the efficacy of a standard intradialytic exercise program (control group) to an individualized, patient-centered, "Move-More" physical activity intervention (intervention group) in hemodialysis (HD) patients. Exercise programs often fail to yield robust benefits for many HD patients, in part because the type and volume of exercise prescribed is inappropriate for a variety of reasons, and the benefits from these studies are often disappointing, as they are characterized by poor adherence, high dropout rates, and modest effects on physical function, body composition, cardiovascular disease risk, and other outcomes related to quality of life (QOL). To address this, the investigators have designed a novel physical activity intervention "Move More" that is designed to overcome many of the barriers to increasing physical activity in this population. This study aims to compare the efficacy of a standard intradialytic exercise program (control group) to an individualized, patient-centered, "Move-More" physical activity intervention (intervention group) in HD patients. The investigators primary hypothesis is that patients randomized to the Move More intervention will increase their physical activity levels more than those in the intradialytic exercise group. The main question it aims to answer is: • Does "Move More" increase the physical activity levels (minutes) measured through weekly minutes of physical activity and the LoPAQ questionnaire more than those in the standard intradialytic exercise program? For secondary outcomes this study aims to answer the following: * Does "Move More" improve the physical function of hemodialysis patients assessed by the short physical performance battery (SPBB) more than those in the standard intradialytic exercise program? * Does "Move More" decrease fatigue assess by the SONG-HD survey more than those in the standard intradialytic exercise program? * Does "Move More" decrease symptoms o
Primary Outcome
Total Minutes of Physical Activity measured with minutes, there is no a minimum or maximin value. If participants increased the total minutes of physical activity this means they increased their physical activity levels.
Conditions Studied
Interventions
- BEHAVIORAL "Move More" Personalized Exercise Program
- BEHAVIORAL Intradialytic Exercise Program
Study Locations (1)
Arizona
- DCI Desert Dialysis - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT06830993 shows while recruiting
NCT06830993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 136-participant average among 12 other Hemodialysis trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Hemodialysis appearing as the primary indexed condition, and to 2 interventions - of which "Move More" Personalized Exercise Program is the first listed.
NCT06830993 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06830993 about?
NCT06830993 is a clinical study titled "Physical Activity Prescription Program for Hemodialysis Patients". The goal of this clinical trial is to compare the efficacy of a standard intradialytic exercise program (control group) to an individualized, patient-centered, "Move-More" physical activity intervention (intervention group) in hemodialysis (HD) patients. Exercise programs often fail to yield robust...
What is the current status of trial NCT06830993?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-01. Estimated completion is 2026-10.
What conditions does trial NCT06830993 study?
This clinical trial studies the following conditions: Hemodialysis.
What interventions are being tested in trial NCT06830993?
The interventions under investigation include: "Move More" Personalized Exercise Program (BEHAVIORAL), Intradialytic Exercise Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06830993?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06830993 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemodialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06830993's enrollment target sits among peer trials
40 9th of 12 higher than 4 of 12 other Hemodialysis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hemodialysis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
RECRUITING · NA
-
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
RECRUITING · NA
-
Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans
ACTIVE NOT RECRUITING · NA
-
Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients
COMPLETED · NA
-
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
COMPLETED · NA
-
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI